190 related articles for article (PubMed ID: 21572642)
1. Vitamin D as a promising anticancer agent.
Chakraborti CK
Indian J Pharmacol; 2011 Apr; 43(2):113-20. PubMed ID: 21572642
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
3. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
Kumagai T; Shih LY; Hughes SV; Desmond JC; O'Kelly J; Hewison M; Koeffler HP
Cancer Res; 2005 Mar; 65(6):2488-97. PubMed ID: 15781666
[TBL] [Abstract][Full Text] [Related]
4. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
5. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Insights of Vitamin D Anticancer Effects.
Ma Y; Johnson CS; Trump DL
Vitam Horm; 2016; 100():395-431. PubMed ID: 26827961
[TBL] [Abstract][Full Text] [Related]
7. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.
Krishnan AV; Swami S; Feldman D
Steroids; 2012 Sep; 77(11):1107-12. PubMed ID: 22801352
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and cancer.
Ali MM; Vaidya V
J Cancer Res Ther; 2007; 3(4):225-30. PubMed ID: 18270398
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D as a Potential Therapeutic Option in Cancer Treatment: Is There a Role for Chemoprevention?
Bahrami A; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(18):2138-2149. PubMed ID: 32729431
[TBL] [Abstract][Full Text] [Related]
13. Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.
Wang JY; Swami S; Krishnan AV; Feldman D
Prostate; 2012 Nov; 72(15):1628-37. PubMed ID: 22457201
[TBL] [Abstract][Full Text] [Related]
14. The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition.
Qi X; Pramanik R; Wang J; Schultz RM; Maitra RK; Han J; DeLuca HF; Chen G
J Biol Chem; 2002 Jul; 277(29):25884-92. PubMed ID: 11983707
[TBL] [Abstract][Full Text] [Related]
15. The anti-cancer actions of vitamin D.
Chiang KC; Chen TC
Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
[TBL] [Abstract][Full Text] [Related]
16. The burgeoning role of cytochrome P450-mediated vitamin D metabolites against colorectal cancer.
Wang P; Qin X; Liu M; Wang X
Pharmacol Res; 2018 Jul; 133():9-20. PubMed ID: 29719203
[TBL] [Abstract][Full Text] [Related]
17. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and prostate cancer.
Tuohimaa P; Lyakhovich A; Aksenov N; Pennanen P; Syvälä H; Lou YR; Ahonen M; Hasan T; Pasanen P; Bläuer M; Manninen T; Miettinen S; Vilja P; Ylikomi T
J Steroid Biochem Mol Biol; 2001; 76(1-5):125-34. PubMed ID: 11384870
[TBL] [Abstract][Full Text] [Related]
19. Loss of the vitamin D receptor in human breast and prostate cancers strongly induces cell apoptosis through downregulation of Wnt/β-catenin signaling.
Zheng Y; Trivedi T; Lin RC; Fong-Yee C; Nolte R; Manibo J; Chen Y; Hossain M; Horas K; Dunstan C; Zhou H; Seibel MJ
Bone Res; 2017; 5():17023. PubMed ID: 28944088
[TBL] [Abstract][Full Text] [Related]
20. 1α,25-Dihydroxyvitamin D
Ben-Eltriki M; Deb S; Guns EST
J Steroid Biochem Mol Biol; 2021 May; 209():105828. PubMed ID: 33493594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
